Khatua Chitta R, Panigrahi Manas K, Choudhury Ashok K, Nath Gautam, Khandelwal Reshu, Anirvan Prajna, Singh Shivaram P
MKCG Medical College and Hospital, Berhampur- 760004, Odisha, India.
All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):225-232. doi: 10.1016/j.jceh.2022.11.008. Epub 2022 Nov 19.
BACKGROUND & AIMS: Severe alcoholic hepatitis (SAH) is a grave condition, and the presence of acute kidney injury (AKI) further jeopardizes patient survival. However, the impact of AKI on survival in SAH has not been assessed from this region of Asia.
This study was conducted on consecutive alcohol-associated liver disease (ALD) patients hospitalized in Gastroenterology Department, SCB Medical College, Cuttack, India, between October 2016 and December 2018. On diagnosis of SAH (mDF score ≥32), demographic, clinical, and laboratory parameters were recorded, and survival was compared between patients with and without AKI (AKIN criteria). In addition, survival was compared among SAH patients defined by other criteria and prognostic models in the presence and absence of AKI.
309 (70.71%) of ALD patients had SAH, and 201 (65%) of them had AKI. SAH patients with AKI had higher total leucocyte count, total bilirubin, serum creatinine, serum urea, INR, MELD (UNOS), MELD (Na+), CTP score, mDF score, Glasgow score, ABIC score, and increased prevalence of acute on chronic liver failure (ACLF) as per EASL-CLIF Consortium criteria ( < 0.001). Further, they had prolonged hospital stay, and increased death during hospitalization, at 28 days as well as 90 days ( < 0.001). Significant differences in survival were also seen in SAH (as per MELD, ABIC, and GAHS criteria) patients above the marked cut offs in respect to AKI.
Over two-thirds of ALD patients had SAH, and about two-thirds had AKI. Patients with SAH and AKI had an increased prevalence of ACLF, longer hospital stay, and increased mortality during hospitalization at 28 days and 90 days.
SAH is a critical condition, and the presence of AKI negatively affects their survival. Hence, early identification of SAH and AKI, as well as early initiation of treatment, is crucial for better survival. Our study from the coastal part of eastern India is the first to demonstrate the prevalence of SAH among patients with ALD along with the prevalence of AKI among SAH patients in this region. This knowledge will be helpful in managing these patients from this region of world.
严重酒精性肝炎(SAH)是一种严重疾病,急性肾损伤(AKI)的存在进一步危及患者生存。然而,亚洲这个地区尚未评估AKI对SAH患者生存的影响。
本研究对2016年10月至2018年12月期间在印度库塔克SCB医学院胃肠病科住院的连续性酒精性肝病(ALD)患者进行。在诊断为SAH(mDF评分≥32)时,记录人口统计学、临床和实验室参数,并比较有和没有AKI(根据AKIN标准)患者的生存率。此外,还比较了在有和没有AKI的情况下,根据其他标准和预后模型定义的SAH患者的生存率。
309例(70.71%)ALD患者患有SAH,其中201例(65%)患有AKI。患有AKI的SAH患者白细胞总数、总胆红素、血清肌酐、血清尿素、国际标准化比值、终末期肝病模型(UNOS)、终末期肝病模型(Na+)、Child-Turcotte-Pugh评分、mDF评分、格拉斯哥评分、ABIC评分更高,并且根据欧洲肝脏研究学会-慢性肝衰竭联盟标准,急性慢性肝衰竭(ACLF)的患病率增加(<0.001)。此外,他们的住院时间延长,住院期间、28天以及90天时的死亡人数增加(<0.001)。在AKI方面,超过显著临界值的SAH(根据终末期肝病模型、ABIC和GAHS标准)患者的生存率也存在显著差异。
超过三分之二的ALD患者患有SAH,约三分之二患有AKI。患有SAH和AKI的患者ACLF患病率增加,住院时间延长,住院期间、28天和90天时死亡率增加。
SAH是一种危急病症,AKI的存在会对其生存产生负面影响。因此,早期识别SAH和AKI以及早期开始治疗对于提高生存率至关重要。我们来自印度东部沿海地区的研究首次证明了该地区ALD患者中SAH的患病率以及SAH患者中AKI的患病率。这些知识将有助于管理来自世界这个地区的这些患者。